In cancer immunotherapy research,
Science is changing the score

Starting with the PD-L1 pathway, Genentech is taking a dynamic approach to research by exploring how to modulate the antitumor immune response

Starting with the PD-L1 pathway, Genentech is taking a dynamic approach to research

Find out more

Exploring Cancer Immunotherapy Research

Discover the science behind our research

Explore now

Immunogenic Cancers

View which tumor types are a focus of exploration

View now

Researching Immunotherapy pathways: PD-L1

See how the PD-L1 pathway enables cancer immune evasion

Learn more

Register For Updates

Stay connected to research, news, and updates

Register now

Resources

View downloadable content summaries and external clinical trial support sites

Search now

For Your Patients

Access educational information on cancer and clinical trials online

View sites